2BV-23638-97366
3 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 681 / NE
- Registered
- 2021-12-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-18
Dose 1 — Pfizer-BioNTech
-
2021-02-08
Dose 2 — Pfizer-BioNTech
-
2021-12-07
Registered in v-safe
-
2021-12-07
Dose 3 — Pfizer-BioNTech
- 2021-12-07
-
2021-12-08
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-09
Survey response — days 1–6 daily, dose 3MedDRA: Night sweats — Feeling: Good · Fatigue or tirednessFree text: Night sweatsMedDRA releases: 2024-11 · check-in free text available
- 2021-12-10
- 2021-12-11
- 2021-12-12
- 2021-12-13
- 2021-12-14
- 2021-12-21
- 2021-12-28
- 2022-01-04
- 2022-01-11
- 2022-01-18
- 2022-03-08
- 2022-06-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-18 | Pfizer-BioNTech | No |
| 2 | 2021-02-08 | Pfizer-BioNTech | No |
| 3 | 2021-12-07 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Night sweats
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Night sweats | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release